NCT05754021Completed
A Practical Platform for In-Home Remote Monitoring of Cognitive Frailty
Tele-CF: A Practical Platform for Remote Monitoring of Cognitive Frailty
Source: ClinicalTrials.gov · Last updated 14 Feb 2025
Brief summary (registry, in English)
Cognitive frailty, characterized by the coexistence of physical frailty and cognitive impairment, is a robust indicator of cognitive decline. Recognizing its significance, the International Association of Gerontology and Geriatrics and the International Academy on Nutrition and Aging have advocated for the use of cognitive frailty assessment as a means of monitoring the progression of mild cognitive impairment towards debilitating conditions like dementia, Alzheimer's disease, and loss of independence. Despite the clear need, a practical and remotely accessible tool for measuring cognitive frailty is currently lacking, especially within the context of telehealth visits. With telehealth video-conferencing becoming increasingly popular, accepted by healthcare payers, and preferred by older adults who may face difficulties traveling to a clinic, there is a pressing need for a software-based solution for remote cognitive frailty assessment that can be easily integrated into existing telehealth systems. This study proposes designing and validating a video-based solution to remotely monitor cognitive-frailty in older adults.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 9 Feb 2023
- Start date
- 1 Feb 2022
- Primary completion date
- 31 Aug 2024
- Lead sponsor
- Baylor College of Medicine
- Diseases
- Alzheimer disease
- NCT number
- NCT05754021
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 1 Feb 2022 to the primary completion date, 31 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Receiving hospice care
Other illness
- Major bilateral upper-limb disorder
- Major hearing/visual impairment
- History of stroke in the last 90 days
- Immobility or major mobility disorder: We will exclude those who were bedbound or unable to stand or ambulate with or without walking assistance
- significant cognitive impairment (MoCA score\<16)
- severe dementia
- history of drug or alcohol abuse over the last six months
Other
- inability to use telemedicine (e.g. no internet at home, severe visual or hearing problem, lack of caregiver support, etc)
- inability or unwillingness to participate in bi-monthly tele-medicine assessments or in-clinic visit (e.g., living farther than 30 mills from the clinic, unavailability of caregivers).
- severe apathy
- severe depression
- in hospice care or palliative care
- unable to communicate in English or Spanish
Who the study is looking for
- 50 years or older
- Ambulatory
- Able and willing to provide consent
- May have a diagnosis of mild dementia or pre-dementia or mild cognitive impairment (MCI), or MoCA score of 26 or lower.
Age in the registry: 50 years to 95 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Baylor College of Medicine Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.